NCT06464302

Brief Summary

The study aims to investigate the effect of surgical stabilisation of rib fractures (SSRF) on clinical outcomes measured during the hospital stay (mortality, days on a mechanical ventilator, intensive care unit and hospital length of stay, rate of complications). Furthermore, the effect of the patients age and overall injury severity on the outcomes after SSRF will be investigated. We hypothesise that the combination of high age and high injury severity will lead to worse outcomes after SSRF.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,064

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 31, 2024

Completed
18 days until next milestone

First Posted

Study publicly available on registry

June 18, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

1.7 years

First QC Date

May 31, 2024

Last Update Submit

April 28, 2026

Conditions

Keywords

Surgical stabilisation of rib fractures (SSRF)

Outcome Measures

Primary Outcomes (2)

  • In hospital-mortality

    Mortality rate from injury to initial hospital discharge, binary

    From injury up to initial hospital discharge or death, whichever came first, assessed up to 2 month.

  • Intensive care unit length of stay

    The duration in days a patient spent in the intensive care unit from the time of hospital admission to the time of initial hospital discharge.

    From injury up to initial hospital discharge or death, whichever came first, assessed up to 2 month.

Secondary Outcomes (7)

  • Intubation rate

    From injury up to initial hospital discharge or death, whichever came first, assessed up to 2 month.

  • Multi-organ failure

    From injury up to initial hospital discharge or death, whichever came first, assessed up to 2 month.

  • Single organ failure

    From injury up to initial hospital discharge or death, whichever came first, assessed up to 2 month.

  • Sepsis

    From injury up to initial hospital discharge or death, whichever came first, assessed up to 2 month.

  • Lung-failure

    From injury up to initial hospital discharge or death, whichever came first, assessed up to 2 month.

  • +2 more secondary outcomes

Study Arms (2)

Operative

Patients receiving surgical stabilisation of rib fractures (SSRF) by any operative technique

Procedure: Surgical stabilisation of rib fractures (SSRF)Other: Non-operative management of rib fractures

Non-operative

Patients not receiving surgical stabilisation of rib fractures (SSRF)

Other: Non-operative management of rib fractures

Interventions

Surgical stabilisation of rib fractures using any fixation technique (including but not limited to plate fixation, intramedullary fixation, wire fixation) via any operative approach (including but not limited to open external approach, minimally invasive approach, thoracoscopic approach, thoracotomy approach).

Operative

Any supportive or specific treatment of rib fractures excluding surgical stabilisation of rib fractures. This includes, but is not limited to analgesia, physiotherapy, non-invasive ventilation, mechanical ventilation, oxygen-supplementation

Non-operativeOperative

Eligibility Criteria

Age0 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The Patients will be sampled from all patients treated in the department for trauma, hand and reconstructive surgery of the university hospital Muenster

You may qualify if:

  • Patients of the University Hospital Muenster
  • Coded serial rib fractures (ICD S22.4 and S22.5)
  • Treatment for the rib fractures between 2019 and 2023

You may not qualify if:

  • pathological rib fractures (due to suspected malignancy)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department for trauma, hand and reconstructive surgery, University hospital Muenster

Münster, North Rhine-Westphalia, 48149, Germany

Location

MeSH Terms

Conditions

Rib FracturesFractures, Bone

Condition Hierarchy (Ancestors)

Wounds and InjuriesThoracic Injuries

Study Officials

  • Steffen Rosslenbroich, PD Dr. med.

    Department for trauma, hand and reconstructive surgery, University hospital Muenster

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2024

First Posted

June 18, 2024

Study Start

May 1, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

April 29, 2026

Record last verified: 2026-04

Locations